Need Assistance?
  • US & Canada:
    +
  • UK: +

Kalata B1

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Kalata B1 is an antibacterial peptide isolated from Oldenlandia affinis. It has activity against gram-positive bacteria, gram-negative bacteria and fungi.

Category
Functional Peptides
Catalog number
BAT-012514
Molecular Formula
C117H180N36O39S6
Molecular Weight
2907.3
IUPAC Name
3-[(1R,4S,7S,13S,20S,23S,26S,29R,32S,35S,41S,44S,47R,50S,53R,59S,65S,68S,71R,74S,83S,86R,89S,92S)-20,68-bis(2-amino-2-oxoethyl)-23-(3-carbamimidamidopropyl)-50,65,74,89-tetrakis[(1S)-1-hydroxyethyl]-26-[(1R)-1-hydroxyethyl]-44-(hydroxymethyl)-41-(1H-indol-3-ylmethyl)-13-(2-methylpropyl)-3,6,12,15,19,22,25,28,31,34,40,43,46,49,52,55,58,64,67,70,73,76,79,82,85,88,91,94,97-nonacosaoxo-4,32,83-tri(propan-2-yl)-a,3a,4a,7a,8a,99-hexathia-2,5,11,14,17,18,21,24,27,30,33,39,42,45,48,51,54,57,63,66,69,72,75,78,81,84,87,90,93,96-triacontazaheptacyclo[51.44.4.429,71.447,86.07,11.035,39.059,63]nonahectan-92-yl]propanoic acid
Synonyms
Cyclotide Kalata B1; Gly-Leu-Pro-Val-Cys-Gly-Glu-Thr-Cys-Val-Gly-Gly-Thr-Cys-Asn-Thr-Pro-Gly-Cys-Thr-Cys-Ser-Trp-Pro-Val-Cys-Thr-Arg-Asn
Sequence
(cyclo)-GLPVC(1)GETC(2)VGGTC(3)NTPGC(1)TC(2)SWPVC(3)TRN-(cyclo)
InChI
InChI=1S/C117H180N36O39S6/c1-49(2)32-65-114(190)151-29-18-24-75(151)105(181)144-86(51(5)6)108(184)137-68-43-193-194-44-69-100(176)147-91(56(12)158)113(189)140-71-46-196-197-47-72(141-112(188)90(55(11)157)146-95(171)62(26-27-84(167)168)129-80(163)39-125-93(68)169)101(177)143-85(50(3)4)107(183)127-37-79(162)124-38-82(165)142-88(53(9)155)110(186)139-70(98(174)133-63(34-77(118)160)96(172)149-92(57(13)159)116(192)153-31-17-23-74(153)104(180)126-40-81(164)131-69)45-195-198-48-73(102(178)148-89(54(10)156)111(187)132-61(22-16-28-122-117(120)121)94(170)134-64(35-78(119)161)103(179)150-128-41-83(166)130-65)138-109(185)87(52(7)8)145-106(182)76-25-19-30-152(76)115(191)66(135-97(173)67(42-154)136-99(71)175)33-58-36-123-60-21-15-14-20-59(58)60/h14-15,20-21,36,49-57,61-76,85-92,123,128,154-159H,16-19,22-35,37-48H2,1-13H3,(H2,118,160)(H2,119,161)(H,124,162)(H,125,169)(H,126,180)(H,127,183)(H,129,163)(H,130,166)(H,131,164)(H,132,187)(H,133,174)(H,134,170)(H,135,173)(H,136,175)(H,137,184)(H,138,185)(H,139,186)(H,140,189)(H,141,188)(H,142,165)(H,143,177)(H,144,181)(H,145,182)(H,146,171)(H,147,176)(H,148,178)(H,149,172)(H,150,179)(H,167,168)(H4,120,121,122)/t53-,54+,55-,56-,57-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,85-,86-,87-,88-,89-,90-,91-,92-/m0/s1
InChI Key
UXGKDCRTOGQACC-YMWYTIKZSA-N
Canonical SMILES
CC(C)CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3CSSCC4C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NNCC(=O)N1)CC(=O)N)CCCNC(=N)N)C(C)O)NC(=O)C(NC(=O)C6CCCN6C(=O)C(NC(=O)C(NC5=O)CO)CC7=CNC8=CC=CC=C87)C(C)C)C(=O)NC(C(=O)NC(C(=O)N9CCCC9C(=O)NCC(=O)N4)C(C)O)CC(=O)N)C(C)O)C(C)C)NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCC(=O)O)C(C)O)C(C)O)C(C)C
1. Kalata B1 and Kalata B2 Have a Surfactant-Like Activity in Phosphatidylethanolomine-Containing Lipid Membranes
Charles G Cranfield, Sónia Troeira Henriques, Boris Martinac, Paul Duckworth, David J Craik, Bruce Cornell Langmuir. 2017 Jul 5;33(26):6630-6637. doi: 10.1021/acs.langmuir.7b01642. Epub 2017 Jun 21.
Cyclotides are cyclic disulfide-rich peptides that are chemically and thermally stable and possess pharmaceutical and insecticidal properties. The activities reported for cyclotides correlate with their ability to target phosphatidylethanolamine (PE)-phospholipids and disrupt cell membranes. However, the mechanism by which this disruption occurs remains unclear. In the current study we examine the effect of the prototypic cyclotides, kalata B1 (kB1) and kalata B2 (kB2), on tethered lipid bilayer membranes (tBLMs) using swept frequency electrical impedance spectroscopy. We confirmed that kB1 and kB2 bind to bilayers only if they contain PE-phospholipids. We hypothesize that the increase in membrane conduction and capacitance observed upon addition of kB1 or kB2 is unlikely to result from ion channel like pores but is consistent with the formation of lipidic toroidal pores. This hypothesis is supported by the concentration dependence of effects of kB1 and kB2 being suggestive of a critical micelle concentration event rather than a progressive increase in conduction arising from increased channel insertion. Additionally, conduction behavior is readily reversible when the peptide is rinsed from the bilayer. Our results support a mechanism by which kB1 and kB2 bind to and disrupt PE-containing membranes by decreasing the overall membrane critical packing parameter, as would a surfactant, which then opens or increases the size of existing membrane defects. The cyclotides need not participate directly in the conductive pore but might exert their effect indirectly through altering membrane packing constraints and inducing purely lipidic conductive pores.
2. The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma
Judith Lind, et al. Biomed Pharmacother. 2022 Sep;153:113486. doi: 10.1016/j.biopha.2022.113486. Epub 2022 Aug 2.
Ribosomally synthesized and post-translationally modified peptides, such as plant cyclotides, are a diverse group of natural products well known as templates in drug discovery and therapeutic lead development. The cyclotide kalata B1 (kB1) has previously been discovered as immunosuppressive agent on T-lymphocytes, and a synthetic version of this peptide, [T20K]kB1 (T20K), has been effective in reducing clinical symptoms, such as inflammation and demyelination, in a mouse model of multiple sclerosis. Based on its T-cell modulatory impact we studied the effects of T20K and several analogs on the proliferation of anaplastic large cell lymphoma (ALCL), a heterogeneous group of clinically aggressive diseases associated with poor prognosis. T20K, as a prototype drug candidate, induces apoptosis and a proliferation arrest in human lymphoma T-cell lines (SR786, Mac-2a and the Jurkat E6.1) in a concentration dependent fashion, at least partially via increased STAT5 and p53 signaling. In contrary to its effect on IL-2 signaling in lymphocytes, the cytokine levels are not altered in lymphoma cells. In vivo mouse experiments revealed a promising activity of T20K on these cancer cells including decreased tumor weight and increased apoptosis. This study opens novel avenues for developing cyclotide-based drug candidates for therapy of patients with ALCL.
3. Interaction of cyclotide Kalata B1 protein with model cellular membranes of varied electrostatics
Ritika Gupta, Jyoti Kumari, Soumya Pati, Shailja Singh, Manasi Mishra, Sajal K Ghosh Int J Biol Macromol. 2021 Nov 30;191:852-860. doi: 10.1016/j.ijbiomac.2021.09.147. Epub 2021 Sep 27.
A uni-molecular layer of lipids at air-water interface mimicking one of the leaflets of the cellular membrane provides a simple model to understand the interaction of any foreign molecules with the membrane. Here, the interactions of protein Kalata B1 (KB1) of cyclotide family with the phospholipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt (DPPG), and 1,2-distearoyl-sn-glycero-3-ethylphosphocholine chloride salt (DSEPC) have been investigated. The addition of KB1 induces a change in pressure of the lipid monolayers. The characteristic time of the change in pressure is found to be dependent on the electrostatic nature of the lipid. Even though the protein is weakly surface active, it is capable of modifying the phase behavior and elastic properties of lipid monolayers with differences in their strength and nature making the layers more floppy. The KB1-lipid interaction has been quantified by calculating the excess Gibb's free energy of interaction and the 1-anilino-8-naphthalenesulfonate (ANS) binding studies. The interaction with zwitterionic DPPC and negatively charged DPPG lipids are found to be thermodynamically favorable whereas the protein shows a weaker response to positively charged DSEPC lipid. Therefore, the long ranged electrostatic is the initial driving force for the KB1 to recognize and subsequently attach to a cellular membrane. Thereafter, the hydrophobic region of the protein may penetrate into the hydrophobic core of the membrane via specific amino acid residues.
Online Inquiry
Verification code
Inquiry Basket